U.S. Commercial Real Estate Benefits From Brexit Vote, New Global Classification Sector
Aug 25, 2016 12:00 pm UTC| Business
HOUSTON, Aug. 25, 2016 -- The impact of Brexit will be long and protracted, which will likely result in increased volatility in the capital markets, according to the latest edition of “the BRIEFING,” a Transwestern...
BlueTalon Closes $16 Million Series A Financing Led By Maverick Ventures
Aug 25, 2016 12:00 pm UTC| Business
REDWOOD CITY, Calif., Aug. 25, 2016 -- BlueTalon, Inc., today announced it has closed over $16 million in Series A financing led by Maverick Ventures, with participation from new investor Arsenal Venture Partners and...
Avaap Named Infor Alliance Partner of the Year Third Year in a Row
Aug 25, 2016 12:00 pm UTC| Business
EDISON, N.J., Aug. 25, 2016 -- Avaap, the largest Infor systems integrator, announced today it is the recipient of three 2016 Americas Partner Summit Awards. The three awards include Infor Alliance Partner of the Year,...
NanoString Technologies to Present at Two Upcoming Healthcare Conferences
Aug 25, 2016 12:00 pm UTC| Business
SEATTLE, Aug. 25, 2016 -- NanoString Technologies, Inc.(NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is...
Aug 25, 2016 12:00 pm UTC| Business
KFAR SABA, Israel, Aug. 25, 2016 -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that Dr. Shai Yarkoni,...
Smart Card Alliance and ASIS International Reach Agreement on Continuing Education Credits
Aug 25, 2016 12:00 pm UTC| Business
PRINCETON JUNCTION, N.J., Aug. 25, 2016 -- Individuals who pass the Smart Card Alliance’s Certified System Engineer ICAM PACS (CSEIP) exam may now be eligible to receive Continuing Education credits or Continuing...
Bioblast Pharma Reports Second Quarter 2016 Financial Results
Aug 25, 2016 12:00 pm UTC| Business
TEL AVIV, Israel, Aug. 25, 2016 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the second quarter ended June 30, 2016. The...